There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

Candida auris has emerged as a formidable global health threat, largely due to its propensity for multidrug resistance and hospital-acquired transmission. This fungal pathogen challenges conventional ...

A new synthetic antibiotic appears to be effective against deadly drug-resistant pathogens, a timely development in the scramble to find solutions for the growing problem of antimicrobial resistance.

Multidrug-resistant bacterial infections that cannot be treated by any known antibiotics pose a serious global threat. A research team has now introduced a method for the development of novel ...

Multidrug resistance in Gram-negative bacteria represents a major public health challenge, with these organisms evolving a myriad of mechanisms to evade the effects of antibiotic treatment. One ...

In recent years, the World Health Organization (WHO) has repeatedly warned of the increase in microbes resistant to antibiotics. Especially multi-resistant bacteria threaten the global healthcare ...

WHO’s director of antimicrobial resistance, Dr Yvan Hutin, says science needs to catch up with drug-resistant bacteria.

A new class of antibiotics has demonstrated fast-acting, potent activity against two of the WHO’s priority pathogens. Researchers from the University of Liverpool (UK) have developed NovItex, a new ...

Regional efforts to curb multidrug-resistant organisms (MDROs) in long-term care facilities and other healthcare settings was linked to fewer cases, hospitalizations and deaths, as well as reduced ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

Infections by antimicrobial resistant (AMR) pathogens are a leading cause of death worldwide, with more than 1 million deaths annually, highlighting the need for new treatments. Researchers have ...

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial ...